Winning Health rejects convertible bond price revision despite trigger
Winning Health Technology Group has decided not to lower the conversion price of its convertible bonds despite meeting the conditions to do so.
The company's stock price triggered the downward revision clause after 15 trading days closed below 85% of the current conversion price of 17.31 yuan per share within a 30-day period as of July 18.
The board resolved not to implement the revision and will not propose any changes for the next three months if conditions are triggered again.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Winning Health Technology Group publishes news
Free account required • Unsubscribe anytime